Your Personalised Weight Loss Journey
Everyone’s weight loss journey is unique. Our medical experts will guide you to the most suitable solution based on your health, lifestyle, and goals:
Dealing with overweight or obesity can be tough, but you don't have to face it by yourself. At Imperial College London Diabetes & Endocrine Centre, our team of specialists, with their vast expertise in obesity management, will help you shed pounds and gain health.
Obesity is a chronic, relapsing neuro-behavioural disease caused by a combination of genetic susceptibility and environmental factors. Historically, it has been perceived as a lifestyle choice, leading to advice to 'eat less' and 'move more,' which is often unsuccessful. We recognise obesity as a chronic disease and are committed to providing individualised treatment options tailored to your needs and preferences, ensuring you receive the best possible care.
Everyone’s weight loss journey is unique. Our medical experts will guide you to the most suitable solution based on your health, lifestyle, and goals:
Obesity physicians are professionals who have received specialised training and certification in obesity management. At Imperial College London Diabetes & Endocrine Centre, we are proud to have the largest team of obesity physicians within a single institution.
Our SCOPE-certified dietitians and educators collaborate with them to ensure our multi-disciplinary teams provide consistent messaging and holistic care. Our obesity experts work with you to set realistic and achievable goals, offering personalised information and guidance on obesity management. This includes problem-solving strategies, coping tools for stressful situations, and skills to self-manage obesity.
We are proud to be the only centre in Abu Dhabi with published comprehensive long term follow-up data showing assessment of metabolic outcomes pre and post-bariatric surgery for our patients.
For patients with genetic forms of obesity, we provide targeted treatment and precision medicine approaches - ensuring personalised, effective care based on your unique genetic profile.
The Department of Health – Abu Dhabi has introduced a new daily oral medication for obesity management as part of its Personalised Weight Management Programme. This includes next-generation treatments such as orforglipron, designed to support effective and sustained weight loss under medical supervision.
Yes. Unlike traditional GLP-1 treatments that require injections, this new option is taken as a daily tablet. It offers a more convenient alternative for patients who prefer a non-injectable approach to medically supervised weight loss.
The medication works by mimicking the GLP-1 hormone in the body, helping to regulate appetite, reduce food intake, and increase feelings of fullness. This supports gradual and sustainable weight loss when combined with medical guidance.
You may be eligible if you have obesity (BMI of 30 or above), or if you are overweight with related conditions such as type 2 diabetes, fatty liver disease, sleep apnoea, ischaemic heart disease, hypertension, or metabolic disorders. Eligibility is determined following a comprehensive clinical assessment by a specialist.
No. As part of the Department of Health programme, the medication is only prescribed within a structured, physician-led care model that includes ongoing monitoring, lifestyle support, and regular follow-ups.
Yes. The treatment is approved for use in the UAE and is prescribed under strict medical supervision. Patients are carefully monitored throughout their treatment to ensure both safety and effectiveness.
Eligible patients can access this treatment through specialised centres such as Imperial College London Diabetes & Endocrine Centre, where a multidisciplinary team provides end-to-end care - from assessment to ongoing management.
Consultant Endocrinologist and Diabetologist
Consultant Endocrinologist and Diabetologist
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant - Family Medicine - SCOPE Certified
Consultant - Family Medicine - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified, EASO National Clinical Fellow
Consultant Endocrinologist and Diabetologist - SCOPE Certified, EASO National Clinical Fellow
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Consultant Endocrinologist and Diabetologist - SCOPE Certified
Healthcare professionals working with one another across all clinical and support services to achieve the best possible results for our patients.
Imperial College London Diabetes & Endocrine Centre (ICLDEC), part of M42 network, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training and public health awareness.
